Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-22-020466
Date:2022-11-14
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
Original Submission Date:

Reporting Person:

MAZELSKY JONATHAN JAY
ONE IDEXX DRIVE
WESTBROOK, ME 04092

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-11-14 M 18,998 a $62.00 81,305 direct
COMMON STOCK 2022-11-14 S 972 d $433.37 80,333 direct
COMMON STOCK 2022-11-14 S 6,385 d $434.26 73,948 direct
COMMON STOCK 2022-11-14 S 2,543 d $435.07 71,405 direct
COMMON STOCK 2022-11-14 S 600 d $435.88 70,805 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT-TO-BUY) 62.0 2022-11-14 deemed execution date M 18,998 (d) 2024-02-13 common stock 18,998 $62.00 0 direct
Footnotes
IDfootnote
f1 represents the weighted average price of the shares sold ranging from a low of $432.67 to a high of $433.65 per share. the undersigned undertakes, upon request by the commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
f2 represents the weighted average price of the shares sold ranging from a low of $433.69 to a high of $434.685 per share. the undersigned undertakes, upon request by the commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
f3 represents the weighted average price of the shares sold ranging from a low of $434.70 to a high of $435.67 per share. the undersigned undertakes, upon request by the commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
f4 represents the weighted average price of the shares sold ranging from a low of $435.77 to a high of $436.04 per share. the undersigned undertakes, upon request by the commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
f5 grant of option to buy 9,499 shares of issuer common stock that became exercisable for 8,244 shares in four equal annual installments beginning february 14, 2015 and for the remaining 1,255 shares on february 14, 2019 without giving effect to the 2-for-1 stock split of idexx laboratories, inc. common stock that occurred on june 15, 2015 (the "stock split"). the number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the stock split.
f6 not applicable.
WhaleWisdom Logo

Elevate your investments